Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
6.99
-0.22 (-3.05%)
Dec 15, 2025, 4:00 PM EST - Market closed
Myriad Genetics Analyst Ratings
Total Analysts
12
Consensus Rating
Buy
Price Target
$11.82
Upside
+69.10%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $9 → $8.5 | Buy | Maintains | $9 → $8.5 | +21.60% | Nov 11, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $6 → $6.5 | Hold | Maintains | $6 → $6.5 | -7.01% | Nov 5, 2025 |
| TD Cowen | TD Cowen | Hold Maintains $8 → $9 | Hold | Maintains | $8 → $9 | +28.76% | Nov 4, 2025 |
| UBS | UBS | Hold Maintains $6 → $8 | Hold | Maintains | $6 → $8 | +14.45% | Nov 4, 2025 |
| Scotiabank | Scotiabank | Buy → Hold Downgrades $20 → $6 | Buy → Hold | Downgrades | $20 → $6 | -14.16% | May 21, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $13 → $9 | Buy | Maintains | $13 → $9 | +28.76% | May 15, 2025 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $22 → $6 | Buy → Hold | Downgrades | $22 → $6 | -14.16% | May 8, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $14 → $8 | Strong Buy | Maintains | $14 → $8 | +14.45% | May 7, 2025 |
| UBS | UBS | Hold Maintains $16 → $7 | Hold | Maintains | $16 → $7 | +0.14% | May 7, 2025 |
| Raymond James | Raymond James | Buy Reiterates $19 → $10 | Buy | Reiterates | $19 → $10 | +43.06% | May 7, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $18 → $14 | Strong Buy | Maintains | $18 → $14 | +100.29% | Apr 17, 2025 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Apr 9, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $24 → $20 | Buy | Maintains | $24 → $20 | +186.12% | Apr 1, 2025 |
| Piper Sandler | Piper Sandler | Hold → Buy Upgrades $12 → $13 | Hold → Buy | Upgrades | $12 → $13 | +78.83% | Mar 12, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $14 → $12 | Hold | Maintains | $14 → $12 | +64.52% | Mar 4, 2025 |
| B of A Securities | B of A Securities | Sell Maintains $13 → $11 | Sell | Maintains | $13 → $11 | +57.37% | Mar 3, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.